Quarterly report pursuant to Section 13 or 15(d)

Segments - Operations and Assets Information (Details)

v3.21.1
Segments - Operations and Assets Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Jan. 01, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]        
Total revenues $ 545,165 $ 211,466    
Operating Income (loss) 38,437 (40,762)    
Depreciation and amortization 19,989 22,052    
Net income (loss) from investment in investees (43) (134)    
Assets 2,519,575     $ 2,473,063
Goodwill 676,162   $ 718,625 680,602
United States        
Segment Reporting Information [Line Items]        
Total revenues 512,871 180,872    
Ireland        
Segment Reporting Information [Line Items]        
Total revenues 7,129 11,901    
Chile        
Segment Reporting Information [Line Items]        
Total revenues 14,152 10,850    
Spain        
Segment Reporting Information [Line Items]        
Total revenues 5,919 4,156    
Israel        
Segment Reporting Information [Line Items]        
Total revenues 2,512 1,707    
Mexico        
Segment Reporting Information [Line Items]        
Total revenues 2,418 1,841    
Other        
Segment Reporting Information [Line Items]        
Total revenues 164 139    
Corporate        
Segment Reporting Information [Line Items]        
Operating Income (loss) (9,420) (8,503)    
Depreciation and amortization 0 60    
Net income (loss) from investment in investees 0 0    
Assets 37,621     28,080
Goodwill 0     0
Pharmaceutical | Operating Segments        
Segment Reporting Information [Line Items]        
Operating Income (loss) (19,157) (14,126)    
Depreciation and amortization 7,413 7,121    
Net income (loss) from investment in investees (43) (134)    
Assets 1,151,771     1,176,245
Goodwill 241,353     245,793
Diagnostics | Operating Segments        
Segment Reporting Information [Line Items]        
Operating Income (loss) 67,014 (18,133)    
Depreciation and amortization 12,576 14,871    
Net income (loss) from investment in investees 0 0    
Assets 1,330,183     1,268,738
Goodwill 434,809     $ 434,809
Services        
Segment Reporting Information [Line Items]        
Total revenues 506,951 170,839    
Services | Corporate        
Segment Reporting Information [Line Items]        
Total revenues 0 0    
Services | Pharmaceutical | Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues 0 0    
Services | Diagnostics | Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues 506,951 170,839    
Products        
Segment Reporting Information [Line Items]        
Total revenues 33,945 31,074    
Products | Corporate        
Segment Reporting Information [Line Items]        
Total revenues 0 0    
Products | Pharmaceutical | Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues 33,945 31,074    
Products | Diagnostics | Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues 0 0    
Transfer of intellectual property and other        
Segment Reporting Information [Line Items]        
Total revenues 4,269 9,553    
Transfer of intellectual property and other | Corporate        
Segment Reporting Information [Line Items]        
Total revenues 0 0    
Transfer of intellectual property and other | Pharmaceutical | Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues 4,269 9,553    
Transfer of intellectual property and other | Diagnostics | Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues $ 0 $ 0